Recurrent Ovarian Cancer Clinical Trials in Nijmegen, Gelderland
2 recruitingNijmegen, Gelderland, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Endometrial CancerRecurrent Ovarian CancerRecurrent Fallopian Tube Cancer+2 more
Regeneron Pharmaceuticals890 enrolled51 locationsNCT03564340
Recruiting
Phase 2Phase 3
Signal TrAnsduction Pathway Activity Analysis in OVarian cancER
Recurrent Ovarian CancerSignal Transduction Pathway DeregulationTherapy-Associated Cancer
Gynaecologisch Oncologisch Centrum Zuid148 enrolled6 locationsNCT03458221